Rare and Autoimmune Diseases:
TCR Treg Therapy
Baudax Bio is a biotechnology company focused on developing and commercializing innovative products for rare and autoimmune diseases.
About Baudax Bio
We are committed to bringing meaningful therapeutic options to patients, healthcare providers, and payers. Our pipeline includes clinical and early-stage product candidates
Our Innovative Portfolio & Pipeline
Our product candidate pipeline includes early-stage product candidates, including recently acquired TCR TReg platform and two novel neuromuscular blocking agents (NMBAs) and a related proprietary chemical reversal agent.
● ○ ○
Baudax Bio, Inc.
Baudax Bio, Inc.Nasdaq: BXRX
Last—
Change—
Volume—
Day Range—
52 Week Range—
Email Alerts
Stay informed and receive company updates straight to your inbox.